Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Management of refractory ascites

Florence Wong

Clin Mol Hepatol. 2023;29(1):16-32. Published online June 9, 2022

DOI: https://doi.org/10.3350/cmh.2022.0104

View: 10733 Download: 914 Web of Science: 13 Crossref: 14

Original Article

The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction

Maha Mohammad Elsabaawy, Shimaa Rashad Abdelhamid, Ayman Alsebaey, Eman Abdelsamee, Manar Abdelaal Obada, Tary Abdelhamid Salman, Eman Rewisha

Clin Mol Hepatol. 2015;21(4):365-371. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.365

View: 10817 Download: 120 Web of Science: 12 Crossref: 12

Editorial

What we know about paracentesis induced circulatory dysfunction?

Jeong Han Kim

Clin Mol Hepatol. 2015;21(4):349-351. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.349

View: 10044 Download: 168 Web of Science: 3 Crossref: 4

Case Report

Transcatheter coil embolization of the inferior epigastric artery in a huge abdominal wall hematoma caused by paracentesis in a patient with liver cirrhosis

Yun Ji Park, Sang Yeon Lee, Seong Hun Kim, In Hee Kim, Sang Wook Kim, Seung Ok Lee

Clin Mol Hepatol. 2011;17(3):233-237. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.233

View: 7165 Download: 60 Crossref: 9

3

Efficacy and Safety of Large Volume Paracentesis in Cirrhotic Patients with Spontaneous Bacterial Peritonitis : A Randomized Prospective Study

Chang Hwan Choi, M.D., Kwang-Hyub Han, M.D., Do Young Kim, M.D., Jae Hee Cho, M.D., Jae Youn Cheong, M.D., Kun Hoon Song, M.D., Chae Yoon Chon, M.D., and Young Myoung Moon, M.D.

Clin Mol Hepatol. 2002;8(1):52-60. Published online January 1, 1970

View: 3633 Download: 73

The Effect of Paracentesis on Pulmonary Function in Patients with Cirrhosis

Min Su Geum , Young Tak Kim , Sung Gon Choi , Chang Hyeong Lee , Young Oh Kweon , Sung Kook Kim , Yong Hwan Choi , Joon Mo Chung

Clin Mol Hepatol. 1997;3(1):50-57.

View: 2606 Download: 20

1 |

Viewed By 6029	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5560	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 5356	MAFLD: How is it different from NAFLD?
Viewed By 5326	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4904	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 208	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 146	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 119	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 109	MAFLD: How is it different from NAFLD?
Cited By 94	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search